Family Office Networks Partners With Advanced Bifurcation Systems

Friday, July 27, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

WEST PALM BEACH, Florida, July 27, 2018 /PRNewswire/ --Family Office Networks announced today that it has partnered with

Advanced Bifurcation Systems (ABS) to introduce its family office members to ABS's new platform, which is a paradigm shift in interventional cardiology.

The ABS platform is protected by 36 issued and 12 pending U.S. and international patents

comprised of over 300 unique claims.  Upon regulatory approval, the company expects that the ABS platform will become the "standard of care" in the $2.5 billion global bifurcation market. Cardiologists immediately recognize the ABS platform's ease-of-use, with the platform avoiding the mechanical and positioning problems associated with current procedures. The ABS platform reduces risk, improves patient outcomes, saves procedure and recovery times, and reduces healthcare costs.

"Coronary artery disease and heart attacks are leading causes of death in the United States and worldwide. One of the many challenges of non-surgical, catheter-based angioplasty is effective treatment of coronary artery disease at a bifurcation, where one artery branches into two smaller arteries. Plaque deposit at bifurcations is a major cause of poor angioplasty outcomes requiring long and repeated procedures as well as continued referral for open chest surgeries," said ABS Chief Executive Officer Charles Laverty. "In response to this challenge, we have disruptive technology for left main heart disease, stenting coronary arteries at their branch points."

ABS is in the process of obtaining regulatory approval in the United States and internationally.

"Since the coronary stent market is estimated to reach $10B by 2025 with bifurcation disease comprising about 25% of this market, ABS represents a great opportunity for family office investors who seek to make a real impact on the future of healthcare. We believe ABS is poised to capture a significant part of this $2.5B market as the only true and complete bifurcating stent delivery platform in the market," said Family Office Networks Founder Andrew Schneider.

For information on FON, please visit or contact Andrew Schneider, Founder and CEO, at or 561-463-4300. For information on ABS, contact CEO Charles A. Laverty at 949-679-7888 or

About Family Office Networks

Family Office Networks is the premier global community for families to share information and intelligence. The team works with a select group of top tier investment managers and sponsors who offer substantial families' access to stellar investment opportunities in areas such as real estate, venture capital, private equity, and hedge funds. In addition, Family Office Networks shares timely thought leadership on topics related to portfolio management, philanthropy, multi-generational wealth management, compliance and regulation, risk management, insurance, training and education. The website is the hub of Family Office Networks with 40,000 users, including 9,000 family offices, and is a go-to resource for news related to family offices.

CONTACT: Charlotte Luer; +1-239-404-6785,

Cision View original content:

SOURCE Family Office Networks

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store